Using AI to analyze heart changes in patients with high blood pressure
Echocardiographic Analysis by Artificial Intelligence in Hypertension
This study is testing if artificial intelligence can help doctors understand heart changes in patients with high blood pressure by analyzing their heart scans and health information.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Pierre-Bénite) |
| Trial ID | NCT06680986 on ClinicalTrials.gov |
What this trial studies
This study aims to develop artificial intelligence tools to analyze echocardiographic data and patient information to better understand cardiac remodeling in individuals with arterial hypertension. By examining routine imaging data, the study seeks to characterize the spectrum of cardiac effects in hypertensive patients, particularly those in ambiguous clinical situations. The research will also focus on creating automated methods for quantifying cardiac function, enhancing the descriptors used in clinical practice for monitoring heart health.
Who should consider this trial
Good fit: Ideal candidates for this study are adults who have undergone comprehensive blood pressure assessments during hospitalization for hypertension.
Not a fit: Patients who are minors or those under curatorship or guardianship will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools and treatment strategies for patients with arterial hypertension.
How similar studies have performed: While the use of AI in medical imaging is gaining traction, this specific approach to analyzing cardiac remodeling in hypertension is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria Patients who underwent a comprehensive blood pressure assessment during hospitalization in the Cardiologic Federation at Croix Rousse Hospital and Lyon Sud Hospital between January 2018 and December 2021. Exclusion Criteria Patients who are minors. Patients under curatorship or guardianship.
Where this trial is running
Pierre-Bénite
- Hopital Lyon Sud — Pierre-Bénite, France (Recruiting)
Study contacts
- Study coordinator: PierreYves COURAND, MD
- Email: pierre-yves.courand@chu-lyon.fr
- Phone: (+33) 04 78 86 57 37
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.